 |
 |
phil, i am interested in learning more about this study, live in the dc area so travel is not a great problem. However, i was recently diagnosed with msa. fortunately i am in the 25% who responds to parkinson's medication. would i be elegablle for this study? thank you. cathy 52/dx pd 47/dx msa 52 Phil Gesotti wrote: > > As some of you know, I have been working on a non-invasive device to > relieve PD symptoms. Our recruitment poster is now approved and I am > authorized to post it on this forum. It is essentially a tactile cueing > device that I have found effective in relieving my sympotoms. The next > stage is to determine how effective it can be for other patients. > > Phil Gesotti 52/dx 46 > *************************************************************************** > > Volunteers with Parkinson's disease needed to test effects of a physical > device on motor symptoms > In conjunction with Lockheed Martin Corporation and NIH, doctors at the > Johns Hopkins University School of Medicine are seeking volunteer > patients with Parkinson's disease (PD) who experience "freezing" or > start hesitation to participate in a clinical trial to assess the > effects of a physical device on the motor symptoms of PD. > > Detailed ad: > PD patients needed for clinical trial of a physical device for symptoms > of PD > Volunteers are needed for a clinical trial to test whether a device, > referred to as a Transcutaneous Electrical Movement Timing Stimulator > (TEMTS), improves the motor symptoms of Parkinson's disease (PD), > including bradykinesia (slowed movements), akinesia (inability to > initiate movements), rigidity, and tremor. The TEMTS device was modeled > after a transcutaneous electrical nerve stimulation (TENS) unit, a safe > and commonly used device to treat pain symptoms. The TEMTS used in this > trial is a lightweight portable battery-operated machine (<2 pounds) > that is inserted into a pouch attached to a belt and worn around the > waist. The device provides alternating pulses of low-level stimulation > to cutaneous electrodes that are placed on the skin over a given > extremity according to the task performed. The purpose of this clinical > trial is to test the effects of the TEMTS device on quantified measures > of motor initiation, speed, tremor, and tone. > > This clinical trial will be limited to patients who experience > disruptive slowness of movement or difficulty initiating movements (also > known as "freezing" or start hesitation). In addition, participants > must be over age 20 (male or female), have a diagnosis of mild to > moderately severe PD (Hoehn and Yahr stage II-IV), be on a stable > regimen of antiparkinsonian medications, and not experience disabling > memory impairment. Subjects with a pacemaker or brain-stimulating > device are not eligible for the study. > > The study will take place at Johns Hopkins Hospital and will require > about 4 hours of testing. The testing can take place over two separate > days. Participants will be provided free parking and compensated $20 > for their time and the costs of traveling to Johns Hopkins. If you are > interested in participating, please contact Melissa Gerstenhaber, R.N., > M.S.N., Research Nurse Coordinator for the Morris K. Udall Parkinson's > Disease Research Center of Excellence at Johns Hopkins (410-614-1242) or > email her at [log in to unmask] The principal investigator of this > study is Laura Marsh, M.D.. Lockheed Martin Corporation and the > National Institutes of Health are providing financial support for the > study. > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn